Boston Scientific Corp Chairman, President and CEO Michael F. Mahoney filed a Form 4 on November 6, 2026, disclosing two gift transactions dated November 4, 2026, involving the transfer of Boston Scientific common stock through two irrevocable trusts.

Key Highlights

  • First gift: 149,992 shares of common stock were acquired at $0.0000 by The Michael F. Mahoney Term Irrevocable Trust - 2025, administered by an independent trustee.
  • Second gift: 102,249 shares of common stock were acquired at $0.0000 by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2024, also administered by an independent trustee.
  • Combined indirect holdings: Following the two transactions, Mahoney holds 252,241 shares indirectly by trust.
  • Direct holdings: The filing lists 1,590,024 shares of common stock held directly.
  • 401(k) holdings: An additional 22,112 shares are held indirectly through the company's 401(k) Retirement Savings Plan, described as reflecting "the most current data available."
  • Transaction code: Both transactions are coded "G," indicating gifts, with a price of $0.0000 per share.

Michael F. Mahoney's November 2026 Trust Gift Transactions at Boston Scientific

According to the filing, Michael F. Mahoney, who serves as Chairman, President and CEO of Boston Scientific Corp (NYSE:BSX), reported two gift transactions on November 4, 2026, each coded "G" under the SEC's transaction code definitions. Both transactions involved the acquisition of common stock at a price of $0.0000, consistent with gift transfers rather than open-market purchases or sales.

The first transaction, as explained in the filing's footnotes, involved a gift of 149,992 shares by The Michael F. Mahoney Term Irrevocable Trust - 2025, which the filing states "is administered by an independent trustee." The second transaction involved a gift of 102,249 shares by The Michael F. Mahoney 2 Year Qualified Annuity Trust - 2024, also described as administered by an independent trustee. Both positions are classified as indirect beneficial ownership held by trust. Following these two reported transactions, Mahoney's indirect trust holdings total 252,241 shares.

The filing also reports that Mahoney holds 1,590,024 shares of common stock directly, and 22,112 shares indirectly through the company's 401(k) Retirement Savings Plan. The 401(k) balance is noted as reflecting "the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan." The Form 4 was signed by Susan Thompson as Attorney-in-Fact and filed on November 6, 2026.

What Was Disclosed

Mahoney's Form 4 disclosed two gift transactions dated November 4, 2026, moving a combined 252,241 shares of Boston Scientific common stock into two separately administered irrevocable trusts, alongside existing direct holdings of 1,590,024 shares and 22,112 shares held in a 401(k) plan.